EUVIMEDEUVIMED entdecken
Crossref

The probability of axillary pathologic complete response in patients with breast radiologic complete response on breast MRI in triple-negative breast cancer treated with neoadjuvant chemotherapy

E. Claassens, F. van Amstel, M. de Boer, U. Lalji, J. Simon, L. Kooreman, M. Smidt, T. van Nijnatten

European Journal of Cancer · 2026-03 · 237 · 116576

DOI: 10.1016/j.ejca.2026.116576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von E. Claassens und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Claassens, E., Amstel, F. V., Boer, M. D., Lalji, U., Simon, J., Kooreman, L., Smidt, M., & Nijnatten, T. V. (2026). The probability of axillary pathologic complete response in patients with breast radiologic complete response on breast MRI in triple-negative breast cancer treated with neoadjuvant chemotherapy. European Journal of Cancer, 237, 116576. https://doi.org/10.1016/j.ejca.2026.116576

Vancouver

Claassens E, Amstel FV, Boer MD, Lalji U, Simon J, Kooreman L, et al. The probability of axillary pathologic complete response in patients with breast radiologic complete response on breast MRI in triple-negative breast cancer treated with neoadjuvant chemotherapy. European Journal of Cancer. 2026;237:116576. doi:10.1016/j.ejca.2026.116576

BibTeX
@article{Claassens2026,
  author = {Claassens, E. and Amstel, F. van and Boer, M. de and Lalji, U. and Simon, J. and Kooreman, L. and Smidt, M. and Nijnatten, T. van},
  title = {The probability of axillary pathologic complete response in patients with breast radiologic complete response on breast MRI in triple-negative breast cancer treated with neoadjuvant chemotherapy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116576},
  doi = {10.1016/j.ejca.2026.116576}
}
Kostenlos starten →